NCT05086848View on ClinicalTrials.gov

A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 5, 2016

Primary Completion Date

June 6, 2018

Study Completion Date

June 6, 2018

Conditions
Advanced Solid Tumors
Interventions
DRUG

Irinotecan liposome、5-fluorouracil、Leucovorin

Irinotecan liposome、5-fluorouracil、Leucovorin

Trial Locations (1)

200032

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05086848 - A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter